A detailed history of National Pension Service transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, National Pension Service holds 511,047 shares of VRTX stock, worth $219 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares
511,047
Previous 461,645 10.7%
Holding current value
$219 Million
Previous $216 Million 9.84%
% of portfolio
0.23%
Previous 0.25%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

BUY
$460.0 - $505.78 $22.7 Million - $25 Million
49,402 Added 10.7%
511,047 $238 Million
Q2 2024

Aug 12, 2024

BUY
$392.81 - $485.53 $2.79 Million - $3.45 Million
7,109 Added 1.56%
461,645 $216 Million
Q1 2024

May 13, 2024

BUY
$407.69 - $446.08 $1.6 Million - $1.75 Million
3,915 Added 0.87%
454,536 $190 Million
Q4 2023

Feb 06, 2024

BUY
$343.0 - $410.68 $3.13 Million - $3.75 Million
9,128 Added 2.07%
450,621 $183 Million
Q3 2023

Nov 14, 2023

BUY
$338.18 - $362.46 $3.03 Million - $3.25 Million
8,959 Added 2.07%
441,493 $154 Million
Q2 2023

Aug 15, 2023

SELL
$314.42 - $351.91 $13.9 Million - $15.6 Million
-44,321 Reduced 9.29%
432,534 $152 Million
Q1 2023

May 11, 2023

BUY
$283.23 - $323.1 $17.2 Million - $19.6 Million
60,763 Added 14.6%
476,855 $150 Million
Q4 2022

Feb 23, 2023

BUY
$285.76 - $321.48 $2.92 Million - $3.29 Million
10,232 Added 2.52%
416,092 $120 Million
Q4 2022

Feb 17, 2023

BUY
$285.76 - $321.48 $2.92 Million - $3.29 Million
10,232 Added 2.52%
416,092 $120 Million
Q3 2022

Feb 23, 2023

SELL
$273.83 - $305.53 $2.8 Million - $3.13 Million
-10,232 Reduced 2.46%
405,860 $118 Million
Q3 2022

Nov 17, 2022

BUY
$273.83 - $305.53 $956,488 - $1.07 Million
3,493 Added 0.87%
405,860 $119 Million
Q2 2022

Aug 17, 2022

BUY
$234.96 - $292.55 $7.4 Million - $9.21 Million
31,483 Added 8.49%
402,367 $113 Million
Q1 2022

May 13, 2022

SELL
$221.42 - $260.97 $1.99 Million - $2.35 Million
-9,006 Reduced 2.37%
370,884 $96.8 Million
Q4 2021

Feb 15, 2022

BUY
$177.01 - $223.45 $1.58 Million - $2 Million
8,944 Added 2.41%
379,890 $83.4 Million
Q3 2021

Nov 18, 2021

SELL
$181.39 - $202.99 $199,528 - $223,289
-1,100 Reduced 0.3%
370,946 $67.3 Million
Q2 2021

Aug 17, 2021

BUY
$187.49 - $221.1 $921,325 - $1.09 Million
4,914 Added 1.34%
372,046 $75 Million
Q1 2021

May 14, 2021

BUY
$207.02 - $241.31 $2.7 Million - $3.15 Million
13,039 Added 3.68%
367,132 $78.9 Million
Q4 2020

Feb 19, 2021

BUY
$207.01 - $276.09 $4.54 Million - $6.05 Million
21,917 Added 6.6%
354,093 $83.7 Million
Q2 2020

Aug 11, 2020

SELL
$225.48 - $295.8 $493,801 - $647,802
-2,190 Reduced 0.65%
332,176 $96.4 Million
Q1 2020

May 27, 2020

BUY
$199.77 - $247.81 $891,173 - $1.11 Million
4,461 Added 1.35%
334,366 $79.6 Million
Q4 2019

Feb 21, 2020

BUY
$166.71 - $223.91 $5.69 Million - $7.64 Million
34,113 Added 11.53%
329,905 $72.2 Million
Q3 2019

Nov 15, 2019

BUY
$166.23 - $187.09 $2.39 Million - $2.69 Million
14,371 Added 5.11%
295,792 $50.1 Million
Q2 2019

Aug 14, 2019

BUY
$164.61 - $190.37 $21,728 - $25,128
132 Added 0.05%
281,421 $51.6 Million
Q1 2019

May 15, 2019

BUY
$163.73 - $194.7 $1.65 Million - $1.97 Million
10,108 Added 3.73%
281,289 $51.7 Million
Q4 2018

Feb 15, 2019

BUY
$151.91 - $192.21 $1.76 Million - $2.22 Million
11,565 Added 4.45%
271,181 $50.4 Million
Q3 2018

Nov 15, 2018

BUY
$167.73 - $192.74 $2.11 Million - $2.42 Million
12,561 Added 5.08%
259,616 $50 Million
Q2 2018

Aug 14, 2018

BUY
$145.72 - $169.96 $2.91 Million - $3.39 Million
19,936 Added 8.78%
247,055 $36.5 Million
Q1 2018

Apr 13, 2018

BUY
$151.6 - $177.13 $1.12 Million - $1.31 Million
7,392 Added 3.36%
227,119 $37 Million
Q4 2017

Jan 17, 2018

SELL
$137.28 - $155.55 $1.28 Million - $1.45 Million
-9,319 Reduced 4.07%
219,727 $32.9 Million
Q3 2017

Oct 16, 2017

BUY
$148.13 - $162.24 $33.9 Million - $37.2 Million
229,046
229,046 $34.3 Million

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $110B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track National Pension Service Portfolio

Follow National Pension Service and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of National Pension Service, based on Form 13F filings with the SEC.

News

Stay updated on National Pension Service with notifications on news.